Cargando…

Stratified analysis reveals chemokine-like factor (CKLF) as a potential prognostic marker in the MSI-immune consensus molecular subtype CMS1 of colorectal cancer

The Colorectal Cancer (CRC) Subtyping Consortium (CRCSC) recently published four consensus molecular subtypes (CMS's) representing the underlying biology in CRC. The Microsatellite Instable (MSI) immune group, CMS1, has a favorable prognosis in early stage disease, but paradoxically has the wor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dunne, Philip D., O'Reilly, Paul G., Coleman, Helen G., Gray, Ronan T., Longley, Daniel B., Johnston, Patrick G., Salto-Tellez, Manuel, Lawler, Mark, McArt, Darragh G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095027/ https://www.ncbi.nlm.nih.gov/pubmed/27153559 http://dx.doi.org/10.18632/oncotarget.9126

Ejemplares similares

Embracing an integromic approach to tissue biomarker research in cancer: Perspectives and lessons learned
por: Li, Gerald, et al.
Publicado: (2017)

Translation of tissue-based artificial intelligence into clinical practice: from discovery to adoption
por: Geaney, Alice, et al.
Publicado: (2023)

cudaMap: a GPU accelerated program for gene expression connectivity mapping
por: McArt, Darragh G, et al.
Publicado: (2013)

Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification
por: Dunne, Philip D., et al.
Publicado: (2017)

Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq Data
por: McArt, Darragh G., et al.
Publicado: (2013)

Evolutionary genetic algorithm identifies IL2RB as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancer
por: Alderdice, Matthew, et al.
Publicado: (2021)

Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer
por: Hutchinson, Ryan A, et al.
Publicado: (2015)

NUQA: Estimating Cancer Spatial and Temporal Heterogeneity and Evolution through Alignment-Free Methods
por: Roddy, Aideen C, et al.
Publicado: (2019)

QuPath: Open source software for digital pathology image analysis
por: Bankhead, Peter, et al.
Publicado: (2017)

KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies
por: Wen, Qing, et al.
Publicado: (2016)

Identification of Candidate Small-Molecule Therapeutics to Cancer by Gene-Signature Perturbation in Connectivity Mapping
por: McArt, Darragh G., et al.
Publicado: (2011)

Particle swarm optimization artificial intelligence technique for gene signature discovery in transcriptomic cohorts
por: Murphy, Ross G., et al.
Publicado: (2022)

Bcl-xL as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in BRAF-mutant stage II and III colon cancer
por: Dunne, Philip D., et al.
Publicado: (2018)

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics
por: O’Reilly, Paul G., et al.
Publicado: (2016)

Chemokine-Like Factor 1 (CKLF-1) is Overexpressed in Keloid Patients: A Potential Indicating Factor for Keloid-Predisposed Individuals
por: Zhang, Mingzi, et al.
Publicado: (2016)

Impact of Variable RNA-Sequencing Depth on Gene Expression Signatures and Target Compound Robustness: Case Study Examining Brain Tumor (Glioma) Disease Progression
por: Stupnikov, Alexey, et al.
Publicado: (2018)

Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatment
por: Buckley, Niamh E., et al.
Publicado: (2016)

Chemokine‐like factor 1 (CKLF1) aggravates neointimal hyperplasia through activating the NF‐κB /VCAM‐1 pathway
por: Liu, Xinnong, et al.
Publicado: (2020)

IHC-based subcellular quantification provides new insights into prognostic relevance of FLIP and procaspase-8 in non-small-cell lung cancer
por: Hutchinson, Ryan A, et al.
Publicado: (2017)

Validation of Next Generation Sequencing Technologies in Comparison to Current Diagnostic Gold Standards for BRAF, EGFR and KRAS Mutational Analysis
por: McCourt, Clare M., et al.
Publicado: (2013)

Transcriptional Profiling of a Patient-Matched Cohort of Glioblastoma (IDH-Wildtype) for Therapeutic Target and Repurposing Drug Identification
por: Roddy, Aideen C., et al.
Publicado: (2023)

Transcriptional upregulation of c-MET is associated with invasion and tumor budding in colorectal cancer
por: Bradley, Conor A., et al.
Publicado: (2016)

Connectivity mapping using a combined gene signature from multiple colorectal cancer datasets identified candidate drugs including existing chemotherapies
por: Wen, Qing, et al.
Publicado: (2015)

The prognostic value of the stem-like group in colorectal cancer using a panel of immunohistochemistry markers
por: Ong, Chee Wee, et al.
Publicado: (2015)

CKLF as a Prognostic Biomarker and Its Association with Immune Infiltration in Hepatocellular Carcinoma
por: Li, Dan, et al.
Publicado: (2023)

Prognostic and therapeutic relevance of FLIP and procaspase-8 overexpression in non-small cell lung cancer
por: Riley, J S, et al.
Publicado: (2013)

Prospective patient stratification into robust cancer‐cell intrinsic subtypes from colorectal cancer biopsies
por: Alderdice, Matthew, et al.
Publicado: (2018)

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer
por: Bibby, Becky A. S., et al.
Publicado: (2021)

Molecular classification of non-invasive breast lesions for personalised therapy and chemoprevention
por: Buckley, Niamh, et al.
Publicado: (2015)

Delivering a research‐enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer Program
por: Lawler, Mark, et al.
Publicado: (2015)

A breakdown of metabolic reprogramming in microglia induced by CKLF1 exacerbates immune tolerance in ischemic stroke
por: Ma, Wen-yu, et al.
Publicado: (2023)

Novel deep learning-based solution for identification of prognostic subgroups in liver cancer (Hepatocellular carcinoma)
por: Owens, Alice R., et al.
Publicado: (2021)

Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia
por: Craig, Stephanie G., et al.
Publicado: (2020)

C19, a C-terminal peptide of CKLF1, decreases inflammation and proliferation of dermal capillaries in psoriasis
por: Zheng, Yi, et al.
Publicado: (2017)

Bioinformatics-Based Discovery of CKLF-Like MARVEL Transmembrane Member 5 as a Novel Biomarker for Breast Cancer
por: Zhou, Juan, et al.
Publicado: (2020)

Research Advances in CKLF-like MARVEL Transmembrane Domain-containing Family in Non-small Cell Lung Cancer
por: Wu, Keheng, et al.
Publicado: (2019)

Automated tumor analysis for molecular profiling in lung cancer
por: Hamilton, Peter W., et al.
Publicado: (2015)

Transcriptional Subtyping and CD8 Immunohistochemistry Identifies Patients With Stage II and III Colorectal Cancer With Poor Prognosis Who Benefit From Adjuvant Chemotherapy
por: Allen, Wendy L., et al.
Publicado: (2018)

Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer
por: Turkington, R C, et al.
Publicado: (2014)

Robustness of differential gene expression analysis of RNA-seq
por: Stupnikov, A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kg9s8dgcb0rr6anat80861era1